Clobot announced in a regulatory filing on the 4th that it has postponed the schedule for its paid-in capital increase, which will be conducted via a public offering of unclaimed shares following a shareholder allotment. This correction is due to a schedule adjustment rather than a change in issuance conditions or the fundraising scale, and the plan to raise approximately 200 billion won remains unchanged.

According to the company, the scheduled number of new shares to be issued is 5,494,500 common shares, and the scheduled issue price remains 36,400 won per share. The total amount to be raised is 200 billion won, of which the allocation remains the same: 37.6638 billion won for operating funds and 162.336 billion won for the acquisition of securities of other corporations. The lead underwriter is Korea Investment & Securities.

The major changes resulting from this schedule postponement are as follows:

• New share allotment reference date: June 9, 2026 → July 7, 2026 • Scheduled date for calculating the finalized issue price: July 10, 2026 → August 10, 2026 • Subscription period for existing shareholders: Previously July 15-16 → August 13-14 • Subscription period for public offering of unclaimed shares: August 19-20 • Payment date: Previously July 24 → August 24 • Scheduled listing date for new shares: Previously August 7 → September 7 • Scheduled end date for short selling prohibition: July 10, 2026 → August 10, 2026

In addition, the company plans to apply to list the share subscription warrants on the Korea Exchange. Upon listing, the trading period will run for five business days, from July 29 to August 4, 2026.